3,3-Dimethyl-7-nitro-2,3-dihydrobenzo[b][1,4]oxazepin-4(5h)-one, 95%, 5g

1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole, 95.0%, 10g

3-Fluoro-5-iodobenzonitrile, 95.0%, 250mg

N-(3,4-Difluorophenyl)-4-methylbenzenesulfonamide, 95%, 5g

1-((2R,3R,4S,5S)-3,5-DIFLUORO-4-HYDROXY-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)PYRIMIDINE-2,4(1H,3H)-DIONE, 90.0%, 1g

(S)-TERT-BUTYL 3-HYDROXYAZEPANE-1-CARBOXYLATE, 95.0%, 500mg

Setaccio di prova Ø 200 mm, 12,5 mm, 1 Pezzo(i)

4-(1H-Imidazol-2-yl)aniline, 95.0%, 250mg

1,4-Dihydro-2H-3,1-benzothiazine-2-thione, 98%, 250mg

4-(4-Chlorophenyl)butyric acid, 95.0%, 100g

2-Amino-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid ethyl ester, 98.0%, 100g

9-Vinylcarbazole>98.0%(GC)25g

Ansa per inoculazione, 2,45 mm 25 pz